BIOMAT Database Logo BIOMAT Database Logo

[Classification of hyperlipidemias and hyperlipoproteinemias]. 1972

J L Beaumont, and L A Carlson, and G R Cooper, and Z Fejfar, and D S Fredrickson, and T Strasser

UI MeSH Term Description Entries
D006949 Hyperlipidemias Conditions with excess LIPIDS in the blood. Hyperlipemia,Hyperlipidemia,Lipemia,Lipidemia,Hyperlipemias,Lipemias,Lipidemias
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D008075 Lipoproteins, HDL A class of lipoproteins of small size (4-13 nm) and dense (greater than 1.063 g/ml) particles. HDL lipoproteins, synthesized in the liver without a lipid core, accumulate cholesterol esters from peripheral tissues and transport them to the liver for re-utilization or elimination from the body (the reverse cholesterol transport). Their major protein component is APOLIPOPROTEIN A-I. HDL also shuttle APOLIPOPROTEINS C and APOLIPOPROTEINS E to and from triglyceride-rich lipoproteins during their catabolism. HDL plasma level has been inversely correlated with the risk of cardiovascular diseases. High Density Lipoprotein,High-Density Lipoprotein,High-Density Lipoproteins,alpha-Lipoprotein,alpha-Lipoproteins,Heavy Lipoproteins,alpha-1 Lipoprotein,Density Lipoprotein, High,HDL Lipoproteins,High Density Lipoproteins,Lipoprotein, High Density,Lipoprotein, High-Density,Lipoproteins, Heavy,Lipoproteins, High-Density,alpha Lipoprotein,alpha Lipoproteins
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D008079 Lipoproteins, VLDL A class of lipoproteins of very light (0.93-1.006 g/ml) large size (30-80 nm) particles with a core composed mainly of TRIGLYCERIDES and a surface monolayer of PHOSPHOLIPIDS and CHOLESTEROL into which are imbedded the apolipoproteins B, E, and C. VLDL facilitates the transport of endogenously made triglycerides to extrahepatic tissues. As triglycerides and Apo C are removed, VLDL is converted to INTERMEDIATE-DENSITY LIPOPROTEINS, then to LOW-DENSITY LIPOPROTEINS from which cholesterol is delivered to the extrahepatic tissues. Pre-beta-Lipoprotein,Prebeta-Lipoprotein,Prebeta-Lipoproteins,Very Low Density Lipoprotein,Very-Low-Density Lipoprotein,Very-Low-Density Lipoproteins,Lipoprotein VLDL II,Lipoproteins, VLDL I,Lipoproteins, VLDL III,Lipoproteins, VLDL1,Lipoproteins, VLDL2,Lipoproteins, VLDL3,Pre-beta-Lipoproteins,Lipoprotein, Very-Low-Density,Lipoproteins, Very-Low-Density,Pre beta Lipoprotein,Pre beta Lipoproteins,Prebeta Lipoprotein,Prebeta Lipoproteins,VLDL Lipoproteins,VLDL1 Lipoproteins,VLDL2 Lipoproteins,VLDL3 Lipoproteins,Very Low Density Lipoproteins
D001796 Blood Protein Disorders Hematologic diseases caused by structural or functional defects of BLOOD PROTEINS. Blood Protein Disorder,Disorder, Blood Protein,Disorders, Blood Protein,Protein Disorder, Blood,Protein Disorders, Blood

Related Publications

J L Beaumont, and L A Carlson, and G R Cooper, and Z Fejfar, and D S Fredrickson, and T Strasser
An international classification of hyperlipidemias and hyperlipoproteinemias.
September 1971, Annals of internal medicine,
J L Beaumont, and L A Carlson, and G R Cooper, and Z Fejfar, and D S Fredrickson, and T Strasser
[Diet therapy of hyperlipidemias (hyperlipoproteinemias)].
May 1977, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
J L Beaumont, and L A Carlson, and G R Cooper, and Z Fejfar, and D S Fredrickson, and T Strasser
[Classification of hyperlipoproteinemias].
February 1974, Dermatologische Monatschrift,
J L Beaumont, and L A Carlson, and G R Cooper, and Z Fejfar, and D S Fredrickson, and T Strasser
[Classification of hyperlipoproteinemias].
April 1974, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi,
J L Beaumont, and L A Carlson, and G R Cooper, and Z Fejfar, and D S Fredrickson, and T Strasser
[Classification of hyperlipoproteinemias].
October 1977, Revista clinica espanola,
J L Beaumont, and L A Carlson, and G R Cooper, and Z Fejfar, and D S Fredrickson, and T Strasser
[Incidence and classification of hyperlipidemias].
May 1967, Helvetica medica acta. Supplementum,
J L Beaumont, and L A Carlson, and G R Cooper, and Z Fejfar, and D S Fredrickson, and T Strasser
[Hyperlipoproteinemias: classification and treatment].
January 1974, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi,
J L Beaumont, and L A Carlson, and G R Cooper, and Z Fejfar, and D S Fredrickson, and T Strasser
Classification and etiology of hyperlipoproteinemias.
January 1971, Federation proceedings,
J L Beaumont, and L A Carlson, and G R Cooper, and Z Fejfar, and D S Fredrickson, and T Strasser
[Classification of the hyperlipoproteinemias].
April 1970, Medizinische Klinik,
J L Beaumont, and L A Carlson, and G R Cooper, and Z Fejfar, and D S Fredrickson, and T Strasser
[Classification of hyperlipidemias in Japan].
July 2007, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!